Efficacy and safety of moxidectin against strongyloidiasis

Simple item page
dc.contributor.authorLuvira V.
dc.contributor.authorWatthanakulpanich D.
dc.contributor.otherMahidol University
dc.date.accessioned2023-11-20T18:01:57Z
dc.date.available2023-11-20T18:01:57Z
dc.date.issued2023-01-01
dc.identifier.citationThe Lancet Infectious Diseases (2023)
dc.identifier.doi10.1016/S1473-3099(23)00558-3
dc.identifier.eissn14744457
dc.identifier.issn14733099
dc.identifier.scopus2-s2.0-85176100714
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/91090
dc.rights.holderSCOPUS
dc.subjectMedicine
dc.titleEfficacy and safety of moxidectin against strongyloidiasis
dc.typeNote
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85176100714&origin=inward
oaire.citation.titleThe Lancet Infectious Diseases
oairecerif.author.affiliationFaculty of Tropical Medicine, Mahidol University

Files

Collections

Scopus 2023